1. 2021
  2. Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL

    Haselager, M., Thijssen, R., West, C., Young, L., van Kampen, R., Willmore, E., Mackay, S., Kater, A. & Eldering, E., May 2021, In: Cell death and differentiation. 28, 5, p. 1658-1668 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

    ERIC, the European Research Initiative on CLL, 11 Mar 2021, In: Blood. 137, 10, p. 1365-1376 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. A bispecific single-domain antibody boosts autologous Vg9Vd2-T cell responses toward CD1d in chronic lymphocytic leukemia

    de Weerdt, I., Lameris, R., Ruben, J. M., de Boer, R., Kloosterman, J., King, L. A., Levin, M-D., Parren, P. W. H. I., de Gruijl, T. D., Kater, A. P. & van der Vliet, H. J., 1 Mar 2021, In: Clinical cancer research. 27, 6, p. 1744-1755 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Human CXCR5+PD-1+ CD8 T cells in healthy individuals and patients with hematologic malignancies

    Hofland, T., Martens, A. W. J., van Bruggen, J. A. C., de Boer, R., Schetters, S., Remmerswaal, E. B. M., Bemelman, F. J., Levin, M-D., Bins, A. D., Eldering, E., Kater, A. P. & Tonino, S. H., Mar 2021, In: European journal of immunology. 51, 3, p. 703-713 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia

    Niemann, C. U., Levin, M-D., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Mattsson, M., Bellido, M., Tran, H. T. T., Nasserinejad, K. & Kater, A. P., 25 Feb 2021, In: Blood. 137, 8, p. 1117-1120 4 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  7. Kinase inhibitors developed for treatment of hematologic malignancies: Implications for immune modulation in COVID-19

    Jacobs, C. F., Eldering, E. & Kater, A. P., 9 Feb 2021, In: Blood advances. 5, 3, p. 913-924 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer

    Leeksma, A. C., Derks, I. A. M., Kasem, M. H., Kilic, E., de Klein, A., Jager, M. J., van de Loosdrecht, A. A., Jansen, J. H., Navrkalova, V., Faber, L. M., Zaborsky, N., Egle, A., Zenz, T., Pospisilova, S., Abdel-Wahab, O., Kater, A. P. & Eldering, E., 29 Jan 2021, In: Frontiers in oncology. 10, 609409.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. A bispecific antibody antagonizes prosurvival CD40 signaling and promotes Vγ9Vδ2 T cell-mediated antitumor responses in human B-cell malignancies

    de Weerdt, I., Lameris, R., Scheffer, G. L., Vree, J., de Boer, R., Stam, A. G., van de Ven, R., Levin, M-D., Pals, S. T., Roovers, R. C., Parren, P. W. H. I., de Gruijl, T. D., Kater, A. P. & van der Vliet, H. J., 1 Jan 2021, In: Cancer immunology research. 9, 1, p. 50-61 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: A multi-center study

    ERIC, the European Research Initiative on CLL, Leeksma, A. C., Baliakas, P., Moysiadis, T., Puiggros, A., Plevova, K., van der Kevie-Kersemaekers, A-M., Posthuma, H., Rodriguez-Vicente, A. E., Tran, A. N., Barbany, G., Mansouri, L., Gunnarsson, R., Parker, H., van den Berg, E., Bellido, M., Davis, Z., Wall, M., Scarpelli, I., Österborg, A., & 19 othersHansson, L., Jarosova, M., Ghia, P., Poddighe, P., Espinet, B., Pospisilova, S., Tam, C., Ysebaert, L., Nguyen-Khac, F., Oscier, D., Haferlach, C., Schoumans, J., Stevens-Kroef, M., Eldering, E., Stamatopoulos, K., Rosenquist, R., Strefford, J. C., Mellink, C. & Kater, A. P., 1 Jan 2021, In: Haematologica. 105, 5

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Eichhorst, B., Robak, T., Montserrat, E., Ghia, P., Niemann, C. U., Kater, A. P., Gregor, M., Cymbalista, F., Buske, C., Hillmen, P., Hallek, M., ESMO Guidelines Committee & Mey, U., Jan 2021, In: Annals of oncology. 32, 1, p. 23-33 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...20 Next

ID: 64520